{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T02:15:32Z","timestamp":1785377732719,"version":"3.55.0"},"update-to":[{"DOI":"10.1002\/14651858.cd008559.pub2","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2017,8,9]],"date-time":"2017-08-09T00:00:00Z","timestamp":1502236800000}}],"reference-count":245,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2017,8,9]],"date-time":"2017-08-09T00:00:00Z","timestamp":1502236800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2017,8,9]],"date-time":"2017-08-09T00:00:00Z","timestamp":1502236800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions"}],"content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd008559.pub3","type":"journal-article","created":{"date-parts":[[2017,8,9]],"date-time":"2017-08-09T02:21:35Z","timestamp":1502245295000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":58,"title":["Atypical antipsychotics for disruptive behaviour disorders in children and youths"],"prefix":"10.1002","volume":"2017","author":[{"given":"Jik H","family":"Loy","sequence":"first","affiliation":[{"name":"Waikato DHB; Child and Adolescent Mental Health; 206 Colllingwood Street Hamilton New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sally N","family":"Merry","sequence":"additional","affiliation":[{"name":"University of Auckland; Department of Psychological Medicine; Private Bag 92019 Auckland New Zealand 1142"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah E","family":"Hetrick","sequence":"additional","affiliation":[{"name":"Orygen, The National Centre of Excellence in Youth Mental Health and The Centre of Youth Mental Health, University of Melbourne; 35 Poplar Road Parkville Melbourne Victoria Australia 3054"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karolina","family":"Stasiak","sequence":"additional","affiliation":[{"name":"University of Auckland; Department of Psychological Medicine; Private Bag 92019 Auckland New Zealand 1142"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2017,8,9]]},"reference":[{"issue":"2","key":"10.1002\/14651858.CD008559.pub3-BIB0001|cit1","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1089\/1044546041649020","article-title":"Risperidone effects in the presence\/absence of psychostimulant medicine in children in ADHD, other disruptive disorders, and subaverage IQ","volume":"14","author":"Aman","year":"2004","journal-title":"Journal of Child and Adolescent Psychopharmacology"},{"issue":"8","key":"10.1002\/14651858.CD008559.pub3-BIB0002|cit2","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1176\/appi.ajp.159.8.1337","article-title":"Double-blind, placebo-controlled study of risperidone for the treatment of disruptive behaviors in children with subaverage intelligence","volume":"159","author":"Aman","year":"2002","journal-title":"American Journal of Psychiatry"},{"issue":"5","key":"10.1002\/14651858.CD008559.pub3-BIB0003|cit3","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1097\/chi.0b013e3180323354","article-title":"Risperidone augmentation for treatment-resistant aggression in attention-deficit\/hyperactivity disorder: a placebo-controlled pilot study","volume":"46","author":"Armenteros","year":"2007","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"issue":"4","key":"10.1002\/14651858.CD008559.pub3-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"239","DOI":"10.4088\/JCP.v62n0405","article-title":"A randomized controlled trial of risperidone in the treatment of aggression in hospitalized adolescents with subaverage cognitive abilities","volume":"62","author":"Buitelaar","year":"2001","journal-title":"Journal of Clinical Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD008559.pub3-BIB0005|cit5","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1089\/cap.2006.0007","article-title":"Randomized controlled pilot study of quetiapine in the treatment of adolescent conduct disorder","volume":"18","author":"Connor","year":"2008","journal-title":"Journal of Child and Adolescent Psychopharmacology"},{"issue":"4","key":"10.1002\/14651858.CD008559.pub3-BIB0006|cit6","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1097\/00004583-200004000-00021","article-title":"A double-blind pilot study of risperidone in the treatment of conduct disorder","volume":"39","author":"Findling","year":"2000","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"key":"10.1002\/14651858.CD008559.pub3-BIB0007|cit7","unstructured":"Fleischhaker C Hennighausen K Schneider-Momm K Schulz E Ziprasidone for severe conduct and other disruptive behavior disorders in children and adolescents - a placebo-controlled, randomized, double-blind clinical trial American Academy of Child and Adolecent Psychiatry (AACAP) and Canadian Academy of Child and Adolescent Psychiatry (CACAP) Joint Meeting; 2011 Oct 18-23; Toronto (CA)"},{"key":"10.1002\/14651858.CD008559.pub3-BIB0008|cit8","unstructured":"NCT00676429 Ziprasidone for severe conduct and other disruptive behavior disorders clinicaltrials.gov\/ct2\/show\/NCT00676429"},{"issue":"3","key":"10.1002\/14651858.CD008559.pub3-BIB0009|cit9","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1176\/appi.ajp.163.3.402","article-title":"A randomized, double-blind, placebo-controlled study of risperidone maintenance treatment in children and adolescents with disruptive behavior disorders","volume":"163","author":"Reyes","year":"2006","journal-title":"American Journal of Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD008559.pub3-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1089\/1044546041649020","article-title":"Risperidone effects in the presence\/absence of psychostimulant medicine in children in ADHD, other disruptive disorders and subaverage IQ","volume":"14","author":"Aman","year":"2004","journal-title":"Journal of Child and Adolescent Psychopharmacology"},{"key":"10.1002\/14651858.CD008559.pub3-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1097\/01.yic.0000166403.03732.72","article-title":"Risperidone reduces aggression in boys with disruptive behaviour disorder and below average intelligence quotient: analysis of two placebo-controlled randomized trials","volume":"20","author":"LeBlanc","year":"2005","journal-title":"International Clinical Psychopharmacology"},{"issue":"9","key":"10.1002\/14651858.CD008559.pub3-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1097\/00004583-200209000-00002","article-title":"Effects of risperidone on conduct and disruptive behavior disorders in children with subaverage IQs","volume":"41","author":"Snyder","year":"2002","journal-title":"Journal of American Academy of Child and Adolescent Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD008559.pub3-BIB0014|cit13","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1089\/cap.2015.2532","article-title":"Treatment of Severe Childhood Aggression (TOSCA) Studies","volume":"25","author":"Aman","year":"2015","journal-title":"Journal of Child and Adolescent Psychopharmacology"},{"issue":"1","key":"10.1002\/14651858.CD008559.pub3-BIB0013|cit14","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.jaac.2013.09.022","article-title":"What does risperidone add to parent training and stimulant for severe aggression in child attention-deficit\/hyperactivity disorder?","volume":"53","author":"Aman","year":"2014","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD008559.pub3-BIB0015|cit15","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1089\/cap.2014.0104","article-title":"Comorbid anxiety and social avoidance in treatment of severe childhood aggression: response to adding risperidone to stimulant and parent training; mediation of disruptive symptom response","volume":"25","author":"Arnold","year":"2015","journal-title":"Journal of Child and Adolescent Psychopharmacology"},{"issue":"1","key":"10.1002\/14651858.CD008559.pub3-BIB0016|cit16","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.jaac.2013.10.007","article-title":"Not just another antipsychotic-for-conduct-problems trial","volume":"53","author":"Blader","year":"2014","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD008559.pub3-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/1753-2000-5-36","article-title":"The treatment of severe child aggression (TOSCA) study: design challenges","volume":"5","author":"Farmer","year":"2011","journal-title":"Child and Adolescent Psychiatry and Mental Health"},{"issue":"3","key":"10.1002\/14651858.CD008559.pub3-BIB0018|cit18","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1089\/cap.2014.0109","article-title":"Comorbid symptomatology moderates response to risperidone, stimulant, and parent training in children with severe aggression, disruptive behavior disorder, and attention-deficit\/hyperactivity disorder","volume":"25","author":"Farmer","year":"2015","journal-title":"Journal of Child and Adolescent Psychopharmacology"},{"issue":"1","key":"10.1002\/14651858.CD008559.pub3-BIB0019|cit19","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1089\/cap.2016.0081","article-title":"The treatment of severe childhood aggression study: 12 weeks of extended, blinded treatment in clinical responders","volume":"27","author":"Findling","year":"2017","journal-title":"Journal of Child and Adolescent Psychopharmacology"},{"issue":"9","key":"10.1002\/14651858.CD008559.pub3-BIB0020|cit20","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1016\/j.jaac.2014.05.008","article-title":"Risperidone added to parent training and stimulant medication: effects on attention-deficit\/hyperactivity disorder, oppositional defiant disorder, conduct disorder, and peer aggression","volume":"53","author":"Gadow","year":"2014","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"issue":"6","key":"10.1002\/14651858.CD008559.pub3-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.jaac.2016.03.014","article-title":"Severely Aggressive Children Receiving Stimulant Medication Versus Stimulant and Risperidone: 12-Month Follow-Up of the TOSCA Trial","volume":"55","author":"Gadow","year":"2016","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"issue":"6","key":"10.1002\/14651858.CD008559.pub3-BIB0022|cit22","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.jaac.2016.03.014","article-title":"Severely aggressive children receiving stimulant medication versus stimulant and risperidone: 12-month follow-up of the TOSCA trial","volume":"55","author":"Gadow","year":"2016","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"issue":"9","key":"10.1002\/14651858.CD008559.pub3-BIB0023|cit23","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1016\/j.jaac.2014.06.008","article-title":"TOSCA: no longer just an opera","volume":"53","author":"Jensen","year":"2014","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"key":"10.1002\/14651858.CD008559.pub3-BIB0024|cit24","unstructured":"NCT00796302 Treatment of severe childhood aggression (the TOSCA study) clinicaltrials.gov\/show\/NCT00796302"},{"issue":"3","key":"10.1002\/14651858.CD008559.pub3-BIB0025|cit25","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1089\/cap.2014.0097","article-title":"Participant satisfaction in a study of stimulant, parent training, and risperidone in children with severe physical aggression","volume":"25","author":"Rundberg-Rivera","year":"2015","journal-title":"Journal of Child and Adolescent Psychopharmacology"},{"issue":"1","key":"10.1002\/14651858.CD008559.pub3-BIB0026|cit26","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1089\/104454601750143348","article-title":"Risperidone in the treatment of behavioral disturbances in children and adolescents with borderline intellectual functioning: a double-blind, placebo-controlled pilot trial","volume":"11","author":"Bellinghen","year":"2001","journal-title":"Journal of Child and Adolescent Psychopharmacology"},{"issue":"12","key":"10.1002\/14651858.CD008559.pub3-BIB0027|cit27","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1176\/appi.ajp.2009.09020233","article-title":"Adjunctive divalproex versus placebo for children with ADHD and aggression refractory to stimulant monotherapy","volume":"166","author":"Blader","year":"2009","journal-title":"American Journal of Psychiatry"},{"issue":"12","key":"10.1002\/14651858.CD008559.pub3-BIB0028|cit28","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1016\/j.jaac.2013.08.024","article-title":"Callous-unemotional traits, proactive aggression, and treatment outcomes of aggressive children with attention-deficit\/hyperactivity disorder","volume":"52","author":"Blader","year":"2013","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD008559.pub3-BIB0029|cit29","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1089\/cap.2000.10.19","article-title":"Open-label treatment with risperidone of 26 psychiatrically hospitalized children and adolescents with mixed diagnoses and aggressive behavior","volume":"10","author":"Buitelaar","year":"2000","journal-title":"Journal of Child and Adolescent Psychopharmacology"},{"issue":"1","key":"10.1002\/14651858.CD008559.pub3-BIB0030|cit30","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1097\/01.chi.0000145805.24274.09","article-title":"Risperidone in children with disruptive behavior disorders and subaverage intelligence: a 1-year, open-label of 504 patients","volume":"44","author":"Croonenberghs","year":"2005","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"issue":"4","key":"10.1002\/14651858.CD008559.pub3-BIB0031|cit31","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1176\/appi.ajp.161.4.677","article-title":"Long-term, open-label study of risperidone in children with severe disruptive behavior disorders and below-average IQ","volume":"161","author":"Findling","year":"2004","journal-title":"The American Journal of Psychiatry"},{"issue":"7","key":"10.1002\/14651858.CD008559.pub3-BIB0032|cit32","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1097\/01.chi.0000219832.23849.31","article-title":"Effectiveness, safety and pharmacokinetics of quetiapine in aggressive children with conduct disorder","volume":"45","author":"Findling","year":"2006","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"issue":"4","key":"10.1002\/14651858.CD008559.pub3-BIB0033|cit33","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1089\/cap.2007.0098","article-title":"Treating disruptive behavior disorders with risperidone: a 1-year, open-label safety study in children and adolescents","volume":"18","author":"Haas","year":"2008","journal-title":"Journal of Child Adolescent Psychopharmacology"},{"issue":"8","key":"10.1002\/14651858.CD008559.pub3-BIB0034|cit34","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1097\/01.chi.0000223312.48406.6e","article-title":"Open-label, prospective trial of olanzapine in adolescents with subaverage intelligence and disruptive behavior disorders","volume":"45","author":"Handen","year":"2006","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"issue":"6","key":"10.1002\/14651858.CD008559.pub3-BIB0035|cit35","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1089\/cap.2013.0029","article-title":"Combination use of atomoxetine hydrochloride and olanzapine in the treatment of attention-deficit\/hyperactivity disorder with comorbid disruptive behavior disorder in children and adolescents 10-18 years of age","volume":"23","author":"Holzer","year":"2013","journal-title":"Journal of Child and Adolescent Psychopharmacology"},{"key":"10.1002\/14651858.CD008559.pub3-BIB0036|cit36","unstructured":"ISRCTN95609637 Relapse prevention in children and adolescents with aggressive behaviour problems treated with risperidone www.isrctn.com\/ISRCTN95609637 10.1186\/ISRCTN95609637"},{"issue":"4","key":"10.1002\/14651858.CD008559.pub3-BIB0037|cit37","first-page":"270","article-title":"An open-label trial of aripiprazole in the treatment of aggression in male adolescents diagnosed with conduct disorder","volume":"23","author":"Kuperman","year":"2011","journal-title":"Annals of Clinical Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD008559.pub3-BIB0038|cit38","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.eurpsy.2004.11.010","article-title":"Olanzapine treatment in adolescents with severe conduct disorder","volume":"21","author":"Masi","year":"2006","journal-title":"European Psychiatry"},{"key":"10.1002\/14651858.CD008559.pub3-BIB0039|cit39","unstructured":"NCT00279409 Treatment of children with ADHD who do not fully respond to stimulants (TREAT) clinicaltrials.gov\/ct2\/show\/NCT00279409"},{"key":"10.1002\/14651858.CD008559.pub3-BIB0040|cit40","unstructured":"NCT00550147 Quetiapine and concerta in the treatment for ADHD and aggressive behavior clinicaltrials.gov\/ct2\/show\/NCT00550147"},{"issue":"2","key":"10.1002\/14651858.CD008559.pub3-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00787-006-0504-0","article-title":"Long-term safety and efficacy of risperidone in children with disruptive behaviour disorder: results of a 2-year extension study","volume":"15","author":"Reyes","year":"2006","journal-title":"European Child & Adolescent Psychiatry"},{"issue":"4","key":"10.1002\/14651858.CD008559.pub3-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"144","DOI":"10.4103\/2231-4040.191425","article-title":"Comparison of the effects of methylphenidate and the combination of methylphenidate and risperidone in preschool children with attention-deficit hyperactivity disorder","volume":"7","author":"Safavi","year":"2016","journal-title":"Journal of Advanced Pharmaceutical Technology & Research"},{"issue":"3","key":"10.1002\/14651858.CD008559.pub3-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1007\/s00787-002-0265-3","article-title":"A clinical case series of six extremely aggressive youths treated with olanzapine","volume":"11","author":"Soderstrom","year":"2002","journal-title":"European Child and Adolescent Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD008559.pub3-BIB0044|cit44","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1089\/cap.2011.0148","article-title":"Clozapine in severe conduct disorder","volume":"23","author":"Teixeira","year":"2013","journal-title":"Journal of Child and Adolescent Psychopharmacology"},{"issue":"5","key":"10.1002\/14651858.CD008559.pub3-BIB0045|cit45","doi-asserted-by":"publisher","first-page":"756","DOI":"10.4088\/JCP.08m04726","article-title":"Aripiprazole in children and adolescents with bipolar disorder comorbid with attention-deficit\/hyperactivity disorder: a pilot randomized clinical trial","volume":"70","author":"Tramontina","year":"2009","journal-title":"Journal of Clinical Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD008559.pub3-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"e34","DOI":"10.1542\/peds.110.3.e34","article-title":"Long-term safety and efficacy of risperidone for the treatment of disruptive behavior disorders in children with subaverage IQs","volume":"110","author":"Turgay","year":"2002","journal-title":"Pediatrics"},{"issue":"9606","key":"10.1002\/14651858.CD008559.pub3-BIB0047|cit47","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S0140-6736(08)60072-0","article-title":"Risperidone, haloperidol and placebo in the treatment of aggressive challenging behaviour in patients with intellectual disability: a randomised controlled trial","volume":"371","author":"Tyrer","year":"2008","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD008559.pub3-BIB0048|cit48","doi-asserted-by":"publisher","first-page":"S134","DOI":"10.1038\/npp.2016.240","article-title":"Children with ADHD and symptoms of opposite defiant disorder improved in behavior when treated with methylphenidate and adjuvant risperidone, though weight gain was also observed","volume":"41","author":"Holsboer-Trachsler","year":"2016","journal-title":"Neuropsychopharmacology"},{"key":"10.1002\/14651858.CD008559.pub3-BIB0049|cit49","unstructured":"IRCT201211051743N10 A double-blind, placebo-controlled study on the efficacy of risperidone adjunctive to methylphenidate in patients with ADHD www.irct.ir\/searchresult.php?id=1743&number=10"},{"key":"10.1002\/14651858.CD008559.pub3-BIB0050|cit50","unstructured":"NCT02063945 Methylphenidate vs. risperidone for the treatment of children and adolescents with ADHD and disruptive disorders clinicaltrials.gov\/ct2\/show\/NCT02063945"},{"key":"10.1002\/14651858.CD008559.pub3-BIB0051|cit51","unstructured":"NCT00794625 Effectiveness of combined medication treatment for aggression in children with attention deficit with hyperactivity disorder (the SPICY study) www.clinicaltrials.gov\/ct2\/show\/NCT00794625"},{"key":"10.1002\/14651858.CD008559.pub3-BIB0052|cit52","article-title":"Parenting Stress Index, Third Edition: Professional Manual.","volume-title":"Psychological Assessment Resources","author":"Abidin","year":"1995"},{"key":"10.1002\/14651858.CD008559.pub3-BIB0053|cit53","volume-title":"Manual for the Child Behavior Checklist\/4-18 and 1991 Profile","author":"Achenbach","year":"1991"},{"issue":"5","key":"10.1002\/14651858.CD008559.pub3-BIB0054|cit54","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1136\/archdischild-2011-300054","article-title":"Review on the current use of antipsychotic drugs in children and adolescents","volume":"96","author":"Almandil","year":"2011","journal-title":"Archives of Disease in Childhood. Education and Practice Edition"},{"issue":"5","key":"10.1002\/14651858.CD008559.pub3-BIB0055|cit55","first-page":"485","article-title":"The aberrant behavior checklist: a behavior rating scale for the assessment of treatment effects","volume":"89","author":"Aman","year":"1985","journal-title":"American Journal of Mental Deficiency"},{"issue":"5","key":"10.1002\/14651858.CD008559.pub3-BIB0056|cit56","first-page":"492","article-title":"Psychometric characteristics of the aberrant behavior checklist","volume":"89","author":"Aman","year":"1985","journal-title":"American Journal of Mental Deficiency"},{"issue":"1","key":"10.1002\/14651858.CD008559.pub3-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/0891-4222(95)00039-9","article-title":"The Nisonger CBRF: a child behavior rating form for children with developmental disabilities","volume":"17","author":"Aman","year":"1996","journal-title":"Research in Developmental Disabilities"},{"issue":"2","key":"10.1002\/14651858.CD008559.pub3-BIB0058|cit58","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1089\/1044546041649020","article-title":"Risperidone effects in the presence\/absence of psychostimulant medicine in children with ADHD, other disruptive disorders, and subaverage IQ","volume":"14","author":"Aman","year":"2004","journal-title":"Journal of Child and Adolescent Psychopharmacology"},{"issue":"4","key":"10.1002\/14651858.CD008559.pub3-BIB0059|cit59","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1097\/YIC.0b013e3282f94ad0","article-title":"The Nisonger Child Behavior Rating Form: typical IQ version","volume":"23","author":"Aman","year":"2008","journal-title":"International Clinical Psychopharmacology"},{"issue":"3","key":"10.1002\/14651858.CD008559.pub3-BIB0060|cit60","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1089\/cap.2015.2532","article-title":"Treatment of Severe Childhood Aggression (TOSCA) Studies","volume":"25","author":"Aman","year":"2015","journal-title":"Journal of Child and Adolescent Psychopharmacology"},{"key":"10.1002\/14651858.CD008559.pub3-BIB0061|cit61","volume-title":"Diagnostic and Statistical Manual of Mental Disorders DSM-IV-TR","author":"American Psychiatric Association","year":"2000"},{"key":"10.1002\/14651858.CD008559.pub3-BIB0062|cit62","doi-asserted-by":"crossref","DOI":"10.1176\/appi.books.9780890425596","volume-title":"Diagnostic and statistical manual of mental disorders (DSM-5)","author":"American Psychiatric Association","year":"2013"},{"key":"10.1002\/14651858.CD008559.pub3-BIB0063|cit63","unstructured":"American Psychiatric Association Highlights of changes from DSM-IV-TR to DSM-5 www.dsm5.org\/documents\/changes%20from%20dsm-iv-tr%20to%20dsm-5.pdf"},{"key":"10.1002\/14651858.CD008559.pub3-BIB0064|cit64","volume-title":"Publication Manual of the American Psychological Association","author":"American Psychological Association","year":"2010"},{"issue":"3","key":"10.1002\/14651858.CD008559.pub3-BIB0065|cit65","first-page":"157","article-title":"Combination and switching of stimulants in children and adolescents with Attention Deficit\/Hyperactivity Disorder in Quebec","volume":"23","author":"Amor","year":"2014","journal-title":"Journal of the Canadian Academy of Child and Adolescent Psychiatry"},{"key":"10.1002\/14651858.CD008559.pub3-BIB0066|cit66","volume-title":"The MacArthur Health and Behavior Questionnaire (HBQ 1.0)","author":"Armstrong","year":"2003"},{"issue":"3","key":"10.1002\/14651858.CD008559.pub3-BIB0067|cit67","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1089\/cap.2014.0104","article-title":"Comorbid anxiety and social avoidance in treatment of severe childhood aggression: response to adding risperidone to stimulant and parent training; mediation of disruptive symptom response","volume":"25","author":"Arnold","year":"2015","journal-title":"Journal of Child and Adolescent Psychopharmacology"},{"issue":"3","key":"10.1002\/14651858.CD008559.pub3-BIB0068|cit68","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3238\/arztebl.2014.0025","article-title":"Antipsychotic prescription in children and adolescents. An analysis of data from a German statutory health insurance company from 2005 to 2012","volume":"111","author":"Bachmann","year":"2014","journal-title":"Deutsches \u00c4rzteblatt International"},{"issue":"3","key":"10.1002\/14651858.CD008559.pub3-BIB0069|cit69","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1037\/a0031972","article-title":"Adult rats treated with risperidone during development are hyperactive","volume":"21","author":"Bardgett","year":"2013","journal-title":"Experimental and Clinical Psychopharmacology."},{"key":"10.1002\/14651858.CD008559.pub3-BIB0070|cit70","volume-title":"Defiant Children: A Clinician's Manual for Assessment and Parent Training","author":"Barkley","year":"1997"},{"key":"10.1002\/14651858.CD008559.pub3-BIB0071|cit71","volume-title":"Attention-Deficit Hyperactivity Disorder: A Handbook for Diagnosis and Treatment","author":"Barkley","year":"2006"},{"issue":"2","key":"10.1002\/14651858.CD008559.pub3-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0165-1781(99)00024-4","article-title":"Impulsive and premeditated aggression: a factor analysis of self-reported acts","volume":"31","author":"Barratt","year":"1999","journal-title":"Psychiatry Research"},{"issue":"12","key":"10.1002\/14651858.CD008559.pub3-BIB0073|cit73","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.2147\/NDT.S100312","article-title":"Disruptive mood dysregulation disorder: current insights","volume":"24","author":"Baweja","year":"2016","journal-title":"Neuropsychiatric Disease and Treatment"},{"issue":"9","key":"10.1002\/14651858.CD008559.pub3-BIB0074|cit74","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1097\/00004583-199609000-00017","article-title":"Is childhood oppositional defiant disorder a precursor to adolescent conduct disorder? Findings from a four year follow up study of children with ADHD","volume":"35","author":"Biederman","year":"1996","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"issue":"7","key":"10.1002\/14651858.CD008559.pub3-BIB0075|cit75","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1017\/S0033291707002668","article-title":"The long-term longitudinal course of oppositional defiant disorder and conduct disorder in ADHD boys: findings from a controlled 10-year prospective longitudinal follow-up study","volume":"38","author":"Biederman","year":"2008","journal-title":"Psychological Medicine"},{"issue":"1","key":"10.1002\/14651858.CD008559.pub3-BIB0076|cit76","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.jaac.2013.10.007","article-title":"Not just another antipsychotic-for-conduct-problems trial","volume":"53","author":"Blader","year":"2014","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"key":"10.1002\/14651858.CD008559.pub3-BIB0077|cit77","unstructured":"BBC Medicines watchdog recalls drugs made in India www.bbc.com\/news\/health-23273101"},{"issue":"4","key":"10.1002\/14651858.CD008559.pub3-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/BF01441569","article-title":"A revised teacher rating scale for reactive and proactive aggression","volume":"24","author":"Brown","year":"1996","journal-title":"Journal of Abnormal Child Psychology"},{"issue":"1","key":"10.1002\/14651858.CD008559.pub3-BIB0079|cit79","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1002\/pds.3897","article-title":"Antipsychotic prescribing for behavioral disorders in US youth: physician specialty, insurance coverage, and complex regimens","volume":"25","author":"Burcu","year":"2016","journal-title":"Pharmacoepidemiology and Drug Safety"},{"issue":"4","key":"10.1002\/14651858.CD008559.pub3-BIB0080|cit80","first-page":"343-9","article-title":"An inventory for assessing different kinds of hostility","volume":"21","author":"Buss","year":"1957","journal-title":"Journal of Consulting and Clinical Psychology"},{"issue":"4","key":"10.1002\/14651858.CD008559.pub3-BIB0081|cit81","first-page":"452-9","article-title":"The aggression questionnaire","volume":"63","author":"Buss","year":"1992","journal-title":"Journal of Personality and Social Psychology"},{"issue":"5","key":"10.1002\/14651858.CD008559.pub3-BIB0082|cit82","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1517\/17425255.2011.562198","article-title":"Antipsychotic drug toxicology in children","volume":"7","author":"Caccia","year":"2011","journal-title":"Expert Opinion on Drug Metabolism and Toxicology"},{"issue":"1","key":"10.1002\/14651858.CD008559.pub3-BIB0083|cit83","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.pcl.2010.11.002","article-title":"Psychopharmacologic control of aggression and violence in children and adolescents","volume":"58","author":"Calles","year":"2011","journal-title":"Pediatric Clinics of North America"},{"issue":"3","key":"10.1002\/14651858.CD008559.pub3-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1002\/1520-6629(199107)19:3<266::AID-JCOP2290190310>3.0.CO;2-5","article-title":"Using a specialized foster care community treatment model for children and adolescents leaving the state mental hospital","volume":"19","author":"Chamberlain","year":"1991","journal-title":"Journal of Community Psychology"},{"issue":"18","key":"10.1002\/14651858.CD008559.pub3-BIB0085|cit85","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.1001\/jama.2016.5453","article-title":"Treatment of attention-deficit\/hyperactivity disorder in adolescents: a systematic review","volume":"315","author":"Chan","year":"2016","journal-title":"Journal of the American Medical Association"},{"issue":"5","key":"10.1002\/14651858.CD008559.pub3-BIB0086|cit86","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009043.pub2","article-title":"Aripiprazole for autism spectrum disorders (ASD)","author":"Ching","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD008559.pub3-BIB0087|cit87","volume-title":"(MATCH-ADTC): Modular Approach to Therapy for Children with Anxiety, Depression, Trauma, or Conduct problems","author":"Chorpita","year":"2009"},{"issue":"10047","key":"10.1002\/14651858.CD008559.pub3-BIB0088|cit88","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/S0140-6736(16)30385-3","article-title":"Comparative efficacy and tolerability of antidepressants for major depressive disorder in children and adolescents: a network meta-analysis","volume":"388","author":"Cipriani","year":"2016","journal-title":"Lancet"},{"issue":"1","key":"10.1002\/14651858.CD008559.pub3-BIB0089|cit89","first-page":"10","article-title":"Assessing emotional and behavioural problems in children: factors associated with multiple informant consistency in New Zealand","volume":"37","author":"Clay","year":"2008","journal-title":"New Zealand Journal of Psychology"},{"issue":"2","key":"10.1002\/14651858.CD008559.pub3-BIB0090|cit90","first-page":"S44","article-title":"Development of neuropharmacologically based behavioral assessments of impulsive aggressive behavior","volume":"3","author":"Coccaro","year":"1991","journal-title":"Journal of Neuropsychiatry and Clinical Neurosciences"},{"issue":"3","key":"10.1002\/14651858.CD008559.pub3-BIB0091|cit91","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0165-1781(97)00119-4","article-title":"Assessment of life history of aggression: development and psychometric characteristics","volume":"73","author":"Coccaro","year":"1997","journal-title":"Psychiatry Research"},{"issue":"6","key":"10.1002\/14651858.CD008559.pub3-BIB0092|cit92","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1111\/j.1469-7610.1993.tb01094.x","article-title":"An epidemiological study of disorders in late childhood and adolescence: age- and gender-specific prevalence","volume":"34","author":"Cohen","year":"1993","journal-title":"Journal of Child Psychology and Psychiatry and Allied Disciplines"},{"issue":"10","key":"10.1002\/14651858.CD008559.pub3-BIB0093|cit93","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1097\/00004583-200310000-00006","article-title":"Ten-year review of rating scales. VI: scales assessing externalising behaviors","volume":"42","author":"Collett","year":"2003","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"key":"10.1002\/14651858.CD008559.pub3-BIB0094|cit94","volume-title":"Manual for Conners Rating Scales: Instruments for Use with Children and Adolescents","author":"Conners","year":"1989"},{"key":"10.1002\/14651858.CD008559.pub3-BIB0095|cit95","volume-title":"Conners Rating Scales-Revised: Technical Manual","author":"Conners","year":"1997"},{"issue":"6","key":"10.1002\/14651858.CD008559.pub3-BIB0096|cit96","doi-asserted-by":"crossref","first-page":"487-97","DOI":"10.1023\/A:1022637815797","article-title":"A new self-report scale for assessment of adolescent psychopathology: factor structure, reliability, validity, and diagnostic sensitivity","volume":"25","author":"Conners","year":"1997","journal-title":"Journal of Abnormal Child Psychology"},{"issue":"5","key":"10.1002\/14651858.CD008559.pub3-BIB0097|cit97","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1097\/DBP.0b013e3181e121bd","article-title":"A review of attention-deficit\/hyperactivity disorder complicated by symptoms of oppositional defiant disorder or conduct disorder","volume":"31","author":"Connor","year":"2010","journal-title":"Journal of Developmental and Behavioral Pediatrics"},{"issue":"Suppl 4","key":"10.1002\/14651858.CD008559.pub3-BIB0098|cit98","first-page":"26","article-title":"Assessing and maximizing the safety and tolerability of antipsychotics used in the treatment of children and adolescents","volume":"69","author":"Correll","year":"2008","journal-title":"Journal of Clinical Psychiatry"},{"issue":"16","key":"10.1002\/14651858.CD008559.pub3-BIB0099|cit99","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1001\/jama.2009.1549","article-title":"Cardiometabolic risk of second generation antipsychotic medications during first time use in children and adolescents","volume":"302","author":"Correll","year":"2009","journal-title":"Journal of the American Medical Association"},{"key":"10.1002\/14651858.CD008559.pub3-BIB0100|cit100","unstructured":"Correll CU Antipsychotic use in youth www.medscape.com\/viewarticle\/718519?src=mp&spon=12&uac=123108CX"},{"key":"10.1002\/14651858.CD008559.pub3-BIB0101|cit101","volume-title":"School Function Assessment User\u2019s Manual","author":"Coster","year":"2008"},{"issue":"3","key":"10.1002\/14651858.CD008559.pub3-BIB0102|cit102","doi-asserted-by":"crossref","first-page":"710","DOI":"10.2307\/1131945","article-title":"Relational aggression, gender and social-psychological adjustment","volume":"66","author":"Crick","year":"1995","journal-title":"Child Development"},{"issue":"4","key":"10.1002\/14651858.CD008559.pub3-BIB0103|cit103","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1097\/00004583-199604000-00014","article-title":"Carbamazepine in aggressive children with conduct disorder: a double-blind and placebo-controlled study","volume":"35","author":"Cueva","year":"1996","journal-title":"Journal of American Academy of Child and Adolescent Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD008559.pub3-BIB0104|cit104","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.eurpsy.2010.09.011","article-title":"Metabolic and endocrine adverse effects of second-generation antipsychotics in children and adolescents: a systematic review of randomized, placebo controlled trials and guidelines for clinical practice","volume":"26","author":"Hert","year":"2011","journal-title":"European Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD008559.pub3-BIB0105|cit105","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1089\/cap.2006.16.273","article-title":"Psychotropic medication utilization in a child and adolescent mental health service","volume":"16","author":"Dean","year":"2006","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"key":"10.1002\/14651858.CD008559.pub3-BIB0106|cit106","unstructured":"Deeks JJ Higgins JPT Altman DG (editors) Chapter 9: Analysing data and undertaking meta-analyses. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions . Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from www.handbook.cochrane.org"},{"issue":"2","key":"10.1002\/14651858.CD008559.pub3-BIB0107|cit107","first-page":"32","article-title":"Recommendations for pharmacological management of inpatient aggression in children and adolescents","volume":"7","author":"Deshmukh","year":"2010","journal-title":"Psychiatry"},{"issue":"9","key":"10.1002\/14651858.CD008559.pub3-BIB0108|cit108","doi-asserted-by":"publisher","first-page":"981","DOI":"10.2217\/pgs.15.55","article-title":"Metabolic side effects and pharmacogenetics of second-generation antipsychotics in children","volume":"16","author":"Devlin","year":"2015","journal-title":"Pharmcogenomics"},{"issue":"6","key":"10.1002\/14651858.CD008559.pub3-BIB0109|cit109","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1037\/0022-3514.53.6.1146","article-title":"Social-information-processing factors in reactive and proactive aggression in children's peer groups","volume":"53","author":"Dodge","year":"1987","journal-title":"Journal of Personality and Social Psychology"},{"issue":"6","key":"10.1002\/14651858.CD008559.pub3-BIB0110|cit110","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1177\/070674370705200605","article-title":"Survey of atypical antipsychotic prescribing by Canadian child psychiatrists and developmental pediatricians for patients aged under 18 years","volume":"52","author":"Doey","year":"2007","journal-title":"Canadian Journal of Psychiatry"},{"issue":"5","key":"10.1002\/14651858.CD008559.pub3-BIB0111|cit111","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1176\/appi.ajp.157.5.818","article-title":"Divalproex treatment for youth with explosive temper and mood lability: a double-blind, placebo-controlled crossover design","volume":"157","author":"Donovan","year":"2000","journal-title":"American Journal of Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD008559.pub3-BIB0112|cit112","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/j.1440-1754.2011.02200.x","article-title":"Efficacy of risperidone in children with disruptive behavioural disorders","volume":"49","author":"Duhig","year":"2013","journal-title":"Journal of Paediatrics and Child Health"},{"issue":"7","key":"10.1002\/14651858.CD008559.pub3-BIB0113|cit113","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphic test","volume":"315","author":"Egger","year":"1997","journal-title":"British Medical Journal"},{"key":"10.1002\/14651858.CD008559.pub3-BIB0114|cit114","volume-title":"Explaining delinquency and drug use","author":"Elliott","year":"1985"},{"key":"10.1002\/14651858.CD008559.pub3-BIB0115|cit115","unstructured":"European Medicines Agency European Medicines Agency decision P\/167\/2011 www.ema.europa.eu\/docs\/en_GB\/document_library\/PIP_decision\/WC500110116.pdf"},{"key":"10.1002\/14651858.CD008559.pub3-BIB0116|cit116","unstructured":"European Medicines Agency Publication and access to clinical-trial data www.ema.europa.eu\/docs\/en_GB\/document_library\/Other\/2013\/06\/WC500144730.pdf"},{"key":"10.1002\/14651858.CD008559.pub3-BIB0117|cit117","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.cpr.2017.01.004","article-title":"Irritability in child and adolescent psychopathology: an integrative review for ICD-11","volume":"53","author":"Evans","year":"2017","journal-title":"Clinical Psychology Review"},{"key":"10.1002\/14651858.CD008559.pub3-BIB0118|cit118","volume-title":"Eyberg Child behaviour Inventory and Sutter-Eyberg Student Behaviour Inventory-Revised","author":"Eyberg","year":"1999"},{"issue":"36","key":"10.1002\/14651858.CD008559.pub3-BIB0119|cit119","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1753-2000-5-36","article-title":"The treatment of severe child aggression (TOSCA) study: design challenges","volume":"5","author":"Farmer","year":"2011","journal-title":"Child and Adolescent Psychiatry and Mental Health"},{"key":"10.1002\/14651858.CD008559.pub3-BIB0120|cit120","unstructured":"FDA US Food and Drug Administration www.fda.gov\/downloads\/AdvisoryCommittees\/CommitteesMeetingMaterials\/PediatricAdvisoryCommittee\/UCM193200.pdf"},{"issue":"8","key":"10.1002\/14651858.CD008559.pub3-BIB0121|cit121","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1111\/1469-7610.00414","article-title":"Early conduct problems and later life opportunities","volume":"39","author":"Fergusson","year":"1998","journal-title":"Journal of Child Psychology and Psychiatry, and Allied Disciplines"},{"issue":"8","key":"10.1002\/14651858.CD008559.pub3-BIB0122|cit122","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1111\/j.1469-7610.2004.00387.x","article-title":"Show me the child at seven: the consequences of conduct problems in childhood for psychosocial functioning in adulthood","volume":"46","author":"Fergusson","year":"2004","journal-title":"Journal of Child Psychology and Psychiatry and Allied Disciplines"},{"key":"10.1002\/14651858.CD008559.pub3-BIB0123|cit123","article-title":"Using antipsychotic medication for the treatment of schizophrenia in children and adolescents","volume-title":"IACAPAP e-Textbook of Child and Adolescent Mental Health","author":"Ferrin","year":"2015"},{"issue":"Suppl 4","key":"10.1002\/14651858.CD008559.pub3-BIB0124|cit124","first-page":"9","article-title":"Atypical antipsychotic treatment of disruptive behavior disorders in children and adolescents","volume":"69","author":"Findling","year":"2008","journal-title":"Journal of Clinical Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD008559.pub3-BIB0125|cit125","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1089\/cap.2016.0081","article-title":"The treatment of severe childhood aggression study: 12 weeks of extended, blinded treatment in clinical responders","volume":"27","author":"Findling","year":"2017","journal-title":"Journal of Child and Adolescent Psychopharmacology"},{"issue":"2","key":"10.1002\/14651858.CD008559.pub3-BIB0126|cit126","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1089\/cap.2015.0061","article-title":"Disruptive mood dysregulation disorder in a community mental health clinic: prevalence, comorbidity and correlates","volume":"26","author":"Freeman","year":"2016","journal-title":"Journal of Child and Adolescent Psychopharmacology"},{"key":"10.1002\/14651858.CD008559.pub3-BIB0127|cit127","volume-title":"Antisocial Process Screening Device (APSD) Technical Manual","author":"Frick","year":"2001"},{"issue":"2","key":"10.1002\/14651858.CD008559.pub3-BIB0128|cit128","doi-asserted-by":"publisher","first-page":"439-46","DOI":"10.1177\/0013164491512018","article-title":"A structural analysis of the State-Trait Anger Expression Inventory","volume":"51","author":"Fuqua","year":"1991","journal-title":"Educational and Psychological Measurement"},{"key":"10.1002\/14651858.CD008559.pub3-BIB0129|cit129","volume-title":"Peer Conflict Scale","author":"Gadow","year":"1986"},{"key":"10.1002\/14651858.CD008559.pub3-BIB0130|cit130","volume-title":"Child and Adolescent Symptom Inventory-4R","author":"Gadow","year":"2005"},{"key":"10.1002\/14651858.CD008559.pub3-BIB0131|cit131","volume-title":"ADHD Symptom Checklist-4 2008 Manual","author":"Gadow","year":"2008"},{"issue":"9","key":"10.1002\/14651858.CD008559.pub3-BIB0132|cit132","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1016\/j.jaac.2014.05.008","article-title":"Risperidone added to parent training and stimulant medication: effects on attention-deficit\/hyperactivity disorder, oppositional defiant disorder, conduct disorder, and peer aggression","volume":"53","author":"Gadow","year":"2014","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"issue":"6","key":"10.1002\/14651858.CD008559.pub3-BIB0133|cit133","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.jaac.2016.03.014","article-title":"Severely aggressive children receiving stimulant medication versus stimulant and risperidone: 12-Month follow-Up of the TOSCA Trial","volume":"55","author":"Gadow","year":"2016","journal-title":"Journal of American Academy of Child and Adolescent Psychiatry."},{"issue":"12","key":"10.1002\/14651858.CD008559.pub3-BIB0134|cit134","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1007\/s00787-013-0498-3","article-title":"Paediatric European Risperidone Studies (PERS): context, rationale, objectives, strategy, and challenges","volume":"23","author":"Glennon","year":"2014","journal-title":"European Child & Adolescent Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD008559.pub3-BIB0135|cit135","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1177\/070674371506000204","article-title":"Canadian guidelines on pharmacotherapy for disruptive and aggressive behaviour in children and adolescents with attention-deficit hyperactivity disorder, oppositional defiant disorder, or conduct disorder","volume":"60","author":"Gorman","year":"2015","journal-title":"Canadian Journal of Psychiatry"},{"key":"10.1002\/14651858.CD008559.pub3-BIB0136|cit136","unstructured":"Grade Working Group, McMaster University GRADEpro GDT 2014"},{"issue":"7","key":"10.1002\/14651858.CD008559.pub3-BIB0137|cit137","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1176\/appi.ajp.159.7.1214","article-title":"Psychiatric comorbidity, family dysfunction, and social impairment on referred youth with oppositional defiant disorder","volume":"159","author":"Greene","year":"2002","journal-title":"American Journal of Psychiatry"},{"issue":"6","key":"10.1002\/14651858.CD008559.pub3-BIB0138|cit138","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1097\/01.CHI.0000046841.56865.37","article-title":"Review of safety assessment methods used in pediatric psychopharmacology","volume":"42","author":"Greenhill","year":"2003","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"issue":"4","key":"10.1002\/14651858.CD008559.pub3-BIB0139|cit139","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1207\/s15374424jccp1404_4","article-title":"The development of the Cleminshaw-Guidubaldi Parent Satisfaction Scale","volume":"14","author":"Guidubaldi","year":"1985","journal-title":"Journal of Clinical Child Psychology"},{"key":"10.1002\/14651858.CD008559.pub3-BIB0140|cit140","volume-title":"ECDEU Assessment Manual for Psychopharmacology","author":"Guy","year":"1976"},{"issue":"3","key":"10.1002\/14651858.CD008559.pub3-BIB0141|cit141","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1097\/00004583-200203000-00003","article-title":"Development, reliability, and validity of the Children's Aggression Scale - Parent Version","volume":"41","author":"Halperin","year":"2002","journal-title":"Journal of American Academy of Child and Adolescent Psychiatry"},{"issue":"8","key":"10.1002\/14651858.CD008559.pub3-BIB0142|cit142","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1097\/01.CHI.0000046899.27264.EB","article-title":"Reliability, validity, and preliminary normative data for the Children's Aggression Scale - Teacher Version","volume":"42","author":"Halperin","year":"2003","journal-title":"Journal of American Academy of Child and Adolescent Psychiatry"},{"issue":"4","key":"10.1002\/14651858.CD008559.pub3-BIB0143|cit143","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s002130050410","article-title":"Central 5-HT depletion enhances impulsive responding without affecting the accuracy of attentional performance: interactions with dopaminergic mechanisms","volume":"133","author":"Harrison","year":"1997","journal-title":"Psychopharmacology"},{"issue":"7","key":"10.1002\/14651858.CD008559.pub3-BIB0144|cit144","doi-asserted-by":"crossref","first-page":"569","DOI":"10.2165\/00002018-200730070-00002","article-title":"Safety and usage of atypical antipsychotic medicines in children: a nationwide prospective cohort study","volume":"30","author":"Harrison-Woolrych","year":"2007","journal-title":"Drug Safety"},{"issue":"11","key":"10.1002\/14651858.CD008559.pub3-BIB0145|cit145","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1176\/appi.ajp.2009.08111747","article-title":"Randomized, single-blind, controlled trial of a specialist behavior therapy team for challenging behavior in adults with intellectual disabilities","volume":"166","author":"Hassiotis","year":"2009","journal-title":"American Journal of Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD008559.pub3-BIB0146|cit146","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1044\/0161-1461(2007\/010)","article-title":"Neurobiology and neurodevelopmental impact of childhood traumatic stress and prenatal alcohol exposure","volume":"38","author":"Henry","year":"2007","journal-title":"Language, Speech, and Hearing Services in Schools"},{"key":"10.1002\/14651858.CD008559.pub3-BIB0147|cit147","unstructured":"Higgins JPT Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"key":"10.1002\/14651858.CD008559.pub3-BIB0148|cit148","unstructured":"Higgins JPT Altman DG Sterne JAC (editors) Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"issue":"6","key":"10.1002\/14651858.CD008559.pub3-BIB0149|cit149","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009043.pub3","article-title":"Aripiprazole for autism spectrum disorders (ASD)","author":"Hirsch","year":"2016","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD008559.pub3-BIB0150|cit150","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1136\/bmj.319.7211.670","article-title":"What is meant by intention to treat analysis? Survey of published randomised controlled trials","volume":"319","author":"Hollis","year":"1999","journal-title":"British Medical Journal"},{"key":"10.1002\/14651858.CD008559.pub3-BIB0151|cit151","doi-asserted-by":"publisher","DOI":"10.1017\/jse.2014.2","volume-title":"Distressed or Deliberately Defiant? Managing Challenging Student Behaviour Due to Trauma and Disorganised Attachment","author":"Howard","year":"2013"},{"issue":"1","key":"10.1002\/14651858.CD008559.pub3-BIB0152|cit152","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s00213-006-0537-6","article-title":"Systematic review of pharmacotherapy of disruptive behaviour disorders in children and adolescents","volume":"191","author":"Ipser","year":"2007","journal-title":"Psychopharmacology"},{"issue":"3","key":"10.1002\/14651858.CD008559.pub3-BIB0153|cit153","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1097\/chi.0b013e31802f1454","article-title":"Consensus report on impulsive aggression as a symptom across diagnostic categories in child psychiatry: implications for medication studies","volume":"46","author":"Jensen","year":"2007","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD008559.pub3-BIB0154|cit154","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1007\/s00787-006-0580-1","article-title":"Management of psychiatric disorders in children and adolescents with atypical antipsychotics: a systematic review of published clinical trials","volume":"16","author":"Jensen","year":"2007","journal-title":"European Child and Adolescent Psychiatry"},{"issue":"9","key":"10.1002\/14651858.CD008559.pub3-BIB0155|cit155","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1016\/j.jaac.2014.06.008","article-title":"TOSCA: no longer just an opera","volume":"53","author":"Jensen","year":"2014","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"issue":"4","key":"10.1002\/14651858.CD008559.pub3-BIB0156|cit156","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1176\/appi.ps.201300391","article-title":"Concurrent use of stimulants and second-generation antipsychotics among children with ADHD enrolled in Medicaid","volume":"66","author":"Kamble","year":"2015","journal-title":"Psychiatric Services (Washington, D.C.)"},{"issue":"4","key":"10.1002\/14651858.CD008559.pub3-BIB0157|cit157","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1007\/s10802-007-9201-9","article-title":"A meta-analytic review of components associated with parent training program effectiveness","volume":"36","author":"Kaminski","year":"2008","journal-title":"Journal of Abnormal Child Psychology"},{"issue":"10","key":"10.1002\/14651858.CD008559.pub3-BIB0158|cit158","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1177\/0004867414538675","article-title":"Longitudinal trends in the dispensing of psychotropic medications in Australia from 2009-2012: focus on children, adolescents and prescriber specialty","volume":"48","author":"Karanges","year":"2014","journal-title":"Australian and New Zealand Journal of Psychiatry"},{"issue":"4","key":"10.1002\/14651858.CD008559.pub3-BIB0159|cit159","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1111\/j.1475-3588.2007.00460.x","article-title":"Evidence for interventions for young offenders","volume":"12","author":"Karnik","year":"2007","journal-title":"Child and Adolescent Mental Health"},{"issue":"9","key":"10.1002\/14651858.CD008559.pub3-BIB0160|cit160","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1097\/00005053-198809000-00007","article-title":"Profiles of aggression among psychiatric patients. I. Nature and prevalence","volume":"176","author":"Kay","year":"1988","journal-title":"Journal of Nervous and Mental Disease"},{"key":"10.1002\/14651858.CD008559.pub3-BIB0161|cit161","doi-asserted-by":"publisher","first-page":"289-303","DOI":"10.1007\/BF00960727","article-title":"The interview for antisocial behavior: psychometric characteristics and concurrent validity with child psychiatric inpatients","volume":"8","author":"Kazdin","year":"1986","journal-title":"Journal of Psychopathology and Behavioral Assessment"},{"issue":"10","key":"10.1002\/14651858.CD008559.pub3-BIB0162|cit162","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1097\/00004583-199710000-00016","article-title":"Parent management training: evidence, outcomes, and issues","volume":"36","author":"Kazdin","year":"1997","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"issue":"6","key":"10.1002\/14651858.CD008559.pub3-BIB0163|cit163","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1097\/01.pra.0000456592.20622.45","article-title":"Predictors of polypharmacy and off-label prescribing of psychotropic medications: a national survey of child and adolescent psychiatrists","volume":"20","author":"Kearns","year":"2014","journal-title":"Journal of Psychiatry Practice"},{"issue":"3","key":"10.1002\/14651858.CD008559.pub3-BIB0164|cit164","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1097\/00004583-199305000-00013","article-title":"Treatment of aggressive children with clonidine: results of an open pilot study","volume":"32","author":"Kemph","year":"1993","journal-title":"Journal of American Academy of Child and Adolescent Psychiatry"},{"issue":"6","key":"10.1002\/14651858.CD008559.pub3-BIB0165|cit165","doi-asserted-by":"publisher","first-page":"e1562","DOI":"10.1542\/peds.2010-1360","article-title":"Treatment of maladaptive aggression in youth: CERT guidelines I. Engagement, assessment, and management","volume":"129","author":"Knapp","year":"2012","journal-title":"Pediatrics"},{"issue":"6","key":"10.1002\/14651858.CD008559.pub3-BIB0166|cit166","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1001\/archpsyc.63.6.622","article-title":"Atypical antipsychotic agents in the treatment of violent patients with schizophrenia and schizoaffective disorder","volume":"63","author":"Krakowsk","year":"2006","journal-title":"Archives of General Psychiatry"},{"issue":"9","key":"10.1002\/14651858.CD008559.pub3-BIB0167|cit167","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1016\/j.jaac.2014.05.010","article-title":"Growth in the concurrent use of antipsychotics with other psychotropic medications in Medicaid-enrolled children","volume":"53","author":"Kreider","year":"2014","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"key":"10.1002\/14651858.CD008559.pub3-BIB0168|cit168","unstructured":"Kuban C Oppositional Defiant Disorder and Trauma. The National Institute for Trauma and Loss in Children www.lianalowenstein.com\/articlesODDKuban.pdf"},{"issue":"5","key":"10.1002\/14651858.CD008559.pub3-BIB0169|cit169","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1097\/01.yic.0000166403.03732.72","article-title":"Risperidone reduces aggression in boys with a disruptive behaviour disorder and below average intelligence quotient: analysis of two placebo-controlled randomized trials","volume":"20","author":"LeBlanc","year":"2005","journal-title":"International Clinical Psychopharmacology"},{"issue":"4","key":"10.1002\/14651858.CD008559.pub3-BIB0170|cit170","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004797.pub4","article-title":"Multisystemic therapy for social, emotional, and behavioral problems in youth aged 10-17","author":"Littell","year":"2005","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD008559.pub3-BIB0171|cit171","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006561","article-title":"Functional Family Therapy for families of youth (age 11-18) with behaviour problems","author":"Littell","year":"2007","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD008559.pub3-BIB0172|cit172","doi-asserted-by":"crossref","DOI":"10.4324\/9781410602930","volume-title":"Antisocial Behavior and Mental Health Problems: Explanatory Factors in Childhood and Adolescence","author":"Loeber","year":"1998"},{"key":"10.1002\/14651858.CD008559.pub3-BIB0173|cit173","unstructured":"Loy J Query for Cochrane Review [personal communication] Email to: M Reyes"},{"key":"10.1002\/14651858.CD008559.pub3-BIB0174|cit174","unstructured":"Loy J Query for Cochrane Review [personal communication] Email to: C Binder"},{"key":"10.1002\/14651858.CD008559.pub3-BIB0175|cit175","unstructured":"Loy J Enquiry regarding TOSCA trial [personal communication] Email to: M Aman"},{"key":"10.1002\/14651858.CD008559.pub3-BIB0176|cit176","unstructured":"Loy J TOSCA statistic related questions [personal communication] Email to: N Brown"},{"key":"10.1002\/14651858.CD008559.pub3-BIB0177|cit177","unstructured":"Loy J Enquiry re SPICY study [personal communication] Email to: J Blader"},{"issue":"1","key":"10.1002\/14651858.CD008559.pub3-BIB0178|cit178","first-page":"41","article-title":"Aggression classification and treatment response","volume":"34","author":"Malone","year":"1998","journal-title":"Psychopharmacology Bulletin"},{"issue":"3","key":"10.1002\/14651858.CD008559.pub3-BIB0179|cit179","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1097\/00004583-199503000-00022","article-title":"The New York Teacher Rating Scale for disruptive and antisocial behavior","volume":"34","author":"Miller","year":"1995","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD008559.pub3-BIB0180|cit180","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1017\/S0954579402001104","article-title":"Males on the life-course-persistent and adolescence-limited antisocial pathway: follow up at age 26 years","volume":"14","author":"Moffitt","year":"2002","journal-title":"Development and Psychopathology"},{"issue":"9263","key":"10.1002\/14651858.CD008559.pub3-BIB0181|cit181","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/S0140-6736(00)04337-3","article-title":"The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials","volume":"357","author":"Moher","year":"2001","journal-title":"Lancet"},{"issue":"7","key":"10.1002\/14651858.CD008559.pub3-BIB0182|cit182","doi-asserted-by":"publisher","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Medicine"},{"key":"10.1002\/14651858.CD008559.pub3-BIB0183|cit183","unstructured":"Multisystemic Therapy \u00ae (MST \u00ae) Research at a Glance January 2016 mstservices.com\/files\/outcomestudies_condensed.pdf 2016"},{"issue":"1","key":"10.1002\/14651858.CD008559.pub3-BIB0184|cit184","first-page":"61","article-title":"A qualitative study of antipsychotic medication experiences of youth","volume":"24","author":"Murphy","year":"2015","journal-title":"Journal of the Canadian Academy of Child and Adolescent Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD008559.pub3-BIB0185|cit185","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1097\/00004583-200202000-00004","article-title":"Ten year review of rating scales. I: overview of scale functioning, psychometric properties, and selection","volume":"41","author":"Myers","year":"2002","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"issue":"7","key":"10.1002\/14651858.CD008559.pub3-BIB0186|cit186","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1038\/nrn2174","article-title":"Neural mechanisms of aggression","volume":"8","author":"Nelson","year":"2007","journal-title":"Nature Reviews. Neuroscience"},{"issue":"2","key":"10.1002\/14651858.CD008559.pub3-BIB0187|cit187","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1037\/a0018059","article-title":"Psychopharmacology of aggression in children and adolescents with primary neuropsychiatric disorders: a review of current and potentially promising treatment options","volume":"18","author":"Nevels","year":"2010","journal-title":"Experimental and Clinical Psychopharmacology"},{"key":"10.1002\/14651858.CD008559.pub3-BIB0188|cit188","unstructured":"NICE National Institute for Health and Care Excellence Clinical guideline CG158 Antisocial behaviour and conduct disorders in children and young people: recognition and management www.nice.org.uk\/guidance\/cg158\/chapter\/1-Recommendations#psychosocial-interventions-treatment-and-indicated-prevention 2013"},{"issue":"1","key":"10.1002\/14651858.CD008559.pub3-BIB0189|cit189","first-page":"13","article-title":"Trends in antipsychotic drug use by very young, privately insured children","volume":"49","author":"Olfson","year":"2010","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"issue":"9","key":"10.1002\/14651858.CD008559.pub3-BIB0190|cit190","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1016\/j.jaac.2014.05.018","article-title":"Combination psychotropic regimens in community practice","volume":"53","author":"Olfson","year":"2014","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"issue":"6","key":"10.1002\/14651858.CD008559.pub3-BIB0191|cit191","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1542\/peds.2008-3782","article-title":"Aripiprazole in the treatment of irritability in children and adolescents with autistic disorder","volume":"124","author":"Owen","year":"2009","journal-title":"Pediatrics"},{"key":"10.1002\/14651858.CD008559.pub3-BIB0192|cit192","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1186\/2193-1801-3-187","article-title":"SENTIA: a systematic online monitoring registry for children and adolescents treated with antipsychotics","volume":"3","author":"Palanca-Maresca","year":"2014","journal-title":"SpringerPlus"},{"issue":"2","key":"10.1002\/14651858.CD008559.pub3-BIB0193|cit193","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/00004583-200302000-00008","article-title":"Treatment recommendations for the use of antipsychotics for aggressive youth (TRAAY). Part II","volume":"42","author":"Pappadopulos","year":"2003","journal-title":"Journal of American Academy of Child and Adolescent Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD008559.pub3-BIB0194|cit194","first-page":"27","article-title":"Pharmacotherapy of aggression in children and adolescents: efficacy and effect size","volume":"15","author":"Pappadopulos","year":"2006","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"issue":"4","key":"10.1002\/14651858.CD008559.pub3-BIB0195|cit195","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/1753-2000-4-9","article-title":"Controversies concerning the diagnosis and treatment of bipolar disorder in children","volume":"10","author":"Parens","year":"2010","journal-title":"Child and Adolescent Psychiatry and Mental Health"},{"key":"10.1002\/14651858.CD008559.pub3-BIB0196|cit196","unstructured":"PERS Pediatric European Risperidone Studies www.pers-project.com\/"},{"issue":"10F","key":"10.1002\/14651858.CD008559.pub3-BIB0197|cit197","first-page":"S982-6","article-title":"Antipsychotic-induced hyperprolactinemia: pathophysiology and clinical consequences","volume":"4","author":"Perkins","year":"2004","journal-title":"Advanced Studies in Medicine"},{"key":"10.1002\/14651858.CD008559.pub3-BIB0198|cit198","first-page":"27","article-title":"Applying principles of neurodevelopment to clinical work with maltreated and traumatized children: the neurosequential model of therapeutics","volume-title":"Working with Traumatized Children in Child Welfare","author":"Perry","year":"2006"},{"issue":"12","key":"10.1002\/14651858.CD008559.pub3-BIB0199|cit199","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1177\/070674371205701203","article-title":"Second-generation antipsychotics for the treatment of disruptive behaviour disorders in children: a systematic review","volume":"57","author":"PringsheimT","year":"2012","journal-title":"Canadian Journal of Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD008559.pub3-BIB0200|cit200","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1177\/070674371506000203","article-title":"The pharmacological management of oppositional behaviour, conduct problems, and aggression in children and adolescents with attention-deficit hyperactivity disorder, oppositional defiant disorder, and conduct disorder: a systematic review and meta-analysis. Part 2: antipsychotics and traditional mood stabilizers","volume":"60","author":"Pringsheim","year":"2015","journal-title":"Canadian Journal of Psychiatry"},{"issue":"5","key":"10.1002\/14651858.CD008559.pub3-BIB0201|cit201","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1542\/peds.2007-2008","article-title":"Epidemiologic feature of antipsychotic prescribing to children and adolescents in primary care in the United Kingdom","volume":"121","author":"Rani","year":"2008","journal-title":"Pediatrics"},{"key":"10.1002\/14651858.CD008559.pub3-BIB0202|cit202","first-page":"1077","article-title":"Rating scales and assessment for use in paediatric psychopharmacology research","volume":"21","author":"Rapoport","year":"1985","journal-title":"Psychopharmacology Bulletin"},{"issue":"4","key":"10.1002\/14651858.CD008559.pub3-BIB0203|cit203","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1503\/jpn.130191","article-title":"Antipsychotic dosing: found in translation","volume":"39","author":"Remington","year":"2014","journal-title":"Journal of Psychiatry and Neuroscience"},{"key":"10.1002\/14651858.CD008559.pub3-BIB0204|cit204","unstructured":"Nordic Cochrane Centre, The Cochrane Collaboration Review Manager 5 (RevMan 5) 2014"},{"issue":"3","key":"10.1002\/14651858.CD008559.pub3-BIB0205|cit205","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1089\/cap.2014.0097","article-title":"Participant satisfaction in a study of stimulant, parent training, and risperidone in children with severe physical aggression","volume":"25","author":"Rundberg-Rivera","year":"2015","journal-title":"Journal of Child and Adolescent Psychopharmacology"},{"issue":"2","key":"10.1002\/14651858.CD008559.pub3-BIB0206|cit206","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1097\/00004583-200302000-00007","article-title":"Treatment recommendations for the use of antipsychotics for aggressive youth (TRAAY). Part 1: a review","volume":"42","author":"Schur","year":"2003","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"key":"10.1002\/14651858.CD008559.pub3-BIB0207|cit207","unstructured":"Sch\u00fcnemann HJ Oxman AD Vist GE Higgins JPT Deeks JJ Glasziou P Guyatt GH Chapter 12: Interpreting results and drawing conclusions. In: Higgins JPT, Green S (editors), Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"issue":"1","key":"10.1002\/14651858.CD008559.pub3-BIB0208|cit208","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1192\/apt.bp.106.002626","article-title":"An update on interventions for conduct disorder","volume":"14","author":"Scott","year":"2008","journal-title":"Advances in Psychiatric Treatment"},{"key":"10.1002\/14651858.CD008559.pub3-BIB0209|cit209","doi-asserted-by":"crossref","unstructured":"Scotto Rosato N Correll CU Pappadopulos E Chait A Crystal S Jensen PS Treatment of maladaptive aggression in youth: CERT guidelines II. Treatments and ongoing management Pediatrics 2012 e1517 86 10.1542\/peds.2010-1361","DOI":"10.1542\/peds.2010-1361"},{"issue":"3","key":"10.1002\/14651858.CD008559.pub3-BIB0210|cit210","doi-asserted-by":"publisher","first-page":"e771","DOI":"10.1542\/peds.2011-2158","article-title":"Antipsychotics for children and young adults: a comparative effectiveness review","volume":"129","author":"Seida","year":"2012","journal-title":"Pediatrics"},{"issue":"11","key":"10.1002\/14651858.CD008559.pub3-BIB0211|cit211","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1001\/archpsyc.1983.01790100074010","article-title":"A children's global assessment scale (CGAS)","volume":"40","author":"Shaffer","year":"1983","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD008559.pub3-BIB0212|cit212","doi-asserted-by":"publisher","first-page":"i65","DOI":"10.1136\/bmj.i65","article-title":"Suicidality and aggression during antidepressant treatment: systematic review and meta-analyses based on clinical study reports","volume":"352","author":"Sharma","year":"2016","journal-title":"British Medical Journal"},{"issue":"1","key":"10.1002\/14651858.CD008559.pub3-BIB0213|cit213","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1097\/00004583-200101000-00014","article-title":"Infant and toddler pathways leading to early externalizing disorders","volume":"40","author":"Shaw","year":"2001","journal-title":"Journal of American Academy of Child and Adolescent Psychiatry"},{"issue":"4","key":"10.1002\/14651858.CD008559.pub3-BIB0214|cit214","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1176\/appi.ajp.2008.07111774","article-title":"Neurobiology of aggression and violence","volume":"165","author":"Siever","year":"2008","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD008559.pub3-BIB0215|cit215","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1600-0447.1970.tb02066.x","article-title":"A rating scale for extrapyramidal side effects","volume":"212","author":"Simpson","year":"1970","journal-title":"Acta Psychiatrica Scandinavica Supplement"},{"issue":"2","key":"10.1002\/14651858.CD008559.pub3-BIB0216|cit216","first-page":"S52","article-title":"Rating aggression in the clinical setting. A retrospective adaptation of the Overt Aggression Scale: preliminary results","volume":"3","author":"Sorgi","year":"1991","journal-title":"Journal of Neuropsychiatry and Clinical Neurosciences"},{"key":"10.1002\/14651858.CD008559.pub3-BIB0217|cit217","first-page":"129","article-title":"Chapter 5 Antipsychotic agents","volume-title":"Stahl's Essential Psychopharmacology Neuroscientific Basis and Practical Applications","author":"Stahl","year":"2013"},{"issue":"Pt 2","key":"10.1002\/14651858.CD008559.pub3-BIB0218|cit218","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/j.2044-8260.1996.tb01184.x","article-title":"Validity and reliability of the Parent Satisfaction Questionnaire","volume":"35","author":"Stallard","year":"1996","journal-title":"British Journal of Clinical Psychology"},{"key":"10.1002\/14651858.CD008559.pub3-BIB0219|cit219","unstructured":"Stasiak K Seeking information on your trial \"Ziprasidone for Severe Conduct and Other Disruptive Behavior Disorders\" (NCT00676429)(personal communication) Email to: K Hennighausen and E Schulz"},{"issue":"Suppl 10","key":"10.1002\/14651858.CD008559.pub3-BIB0220|cit220","doi-asserted-by":"crossref","first-page":"122S","DOI":"10.1097\/00004583-199710001-00008","article-title":"Practice parameters for the assessment and treatment of children and adolescents with conduct disorder","volume":"36","author":"Steiner","year":"1997","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"issue":"4","key":"10.1002\/14651858.CD008559.pub3-BIB0221|cit221","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1017\/S1092852900018514","article-title":"Psychopharmacologic strategies for the treatment of aggression in juveniles","volume":"8","author":"Steiner","year":"2003","journal-title":"CNS Spectrums"},{"issue":"1","key":"10.1002\/14651858.CD008559.pub3-BIB0222|cit222","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1097\/01.chi.0000246060.62706.af","article-title":"Practice parameters for the assessment and treatment of children and adolescents with oppositional defiant disorder","volume":"46","author":"Steiner","year":"2007","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"issue":"b2393","key":"10.1002\/14651858.CD008559.pub3-BIB0223|cit223","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1136\/bmj.b2393","article-title":"Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls","volume":"338","author":"Sterne","year":"2009","journal-title":"British Medical Journal"},{"issue":"Suppl 4","key":"10.1002\/14651858.CD008559.pub3-BIB0224|cit224","first-page":"26","article-title":"Neuroreceptor mechanisms of aggression and its treatment","volume":"64","author":"Swann","year":"2003","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1002\/14651858.CD008559.pub3-BIB0225|cit225","volume-title":"School based assessments and interventions for ADD students","author":"Swanson","year":"1992"},{"issue":"1","key":"10.1002\/14651858.CD008559.pub3-BIB0226|cit226","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/0891-4222(95)00037-2","article-title":"The Nisonger Child Behavior Rating Form: age and gender effect and norms","volume":"17","author":"Tass\u00e9","year":"1996","journal-title":"Research in Developmental Disabilities"},{"issue":"7","key":"10.1002\/14651858.CD008559.pub3-BIB0227|cit227","doi-asserted-by":"crossref","first-page":"549","DOI":"10.2165\/00023210-200620070-00002","article-title":"Pharmacological aspects of the treatment of conduct disorder in children and adolescents","volume":"20","author":"Tcheremissine","year":"2006","journal-title":"CNS Drugs"},{"issue":"3","key":"10.1002\/14651858.CD008559.pub3-BIB0228|cit228","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1590\/S2237-60892013000300002","article-title":"Atypical antipsychotics in the treatment of pathological aggression in children and adolescents: literature review and clinical recommendations","volume":"35","author":"Teixeira","year":"2013","journal-title":"Trends in Psychiatry and Psychotherapy"},{"issue":"1","key":"10.1002\/14651858.CD008559.pub3-BIB0229|cit229","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1192\/apt.bp.105.000901","article-title":"Child psychiatry and its relationship with the pharmaceutical industry: theoretical and practical issues","volume":"14","author":"Timimi","year":"2008","journal-title":"Advances in Psychiatric Treatment"},{"issue":"4","key":"10.1002\/14651858.CD008559.pub3-BIB0230|cit230","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1586\/14737175.4.4.623","article-title":"Aggression and disruptive behavior disorders in children and adolescents","volume":"4","author":"Turgay","year":"2004","journal-title":"Expert Review of Neurotherapeutics"},{"key":"10.1002\/14651858.CD008559.pub3-BIB0231|cit231","first-page":"70","article-title":"Rating Scales","volume-title":"Child and Adolescent Psychiatry","author":"Verhulst","year":"2002"},{"issue":"2","key":"10.1002\/14651858.CD008559.pub3-BIB0232|cit232","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1176\/jnp.2.2.189","article-title":"Subtyping aggression in children and adolescents","volume":"2","author":"Vitiello","year":"1990","journal-title":"Journal of Neuropsychiatry and Clinical Neurosciences"},{"issue":"3","key":"10.1002\/14651858.CD008559.pub3-BIB0233|cit233","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1097\/00004583-199703000-00008","article-title":"Subtypes of aggression and their relevance to child psychiatry","volume":"36","author":"Vitiello","year":"1997","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"issue":"9","key":"10.1002\/14651858.CD008559.pub3-BIB0234|cit234","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/j.euroneuro.2009.04.008","article-title":"Antipsychotics in children and adolescents: increasing use, evidence for efficacy and safety concerns","volume":"19","author":"Vitiello","year":"2009","journal-title":"European Neuropsychopharmacology"},{"key":"10.1002\/14651858.CD008559.pub3-BIB0235|cit235","unstructured":"Waknine Y FDA approves extended-release clonidine for pediatric ADHD www.medscape.com\/viewarticle\/730140"},{"issue":"6","key":"10.1002\/14651858.CD008559.pub3-BIB0236|cit236","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1023\/A:1020867831811","article-title":"Reactive aggression in boys with disruptive behaviour disorders: behaviour, physiology, and affect","volume":"30","author":"Waschbusch","year":"2002","journal-title":"Journal of Abnormal Child Psychology"},{"key":"10.1002\/14651858.CD008559.pub3-BIB0237|cit237","doi-asserted-by":"crossref","DOI":"10.1017\/CBO9780511734960","volume-title":"Psychotherapy for Children and Adolescents, Evidence-Based Treatments and Case Examples","author":"Weisz","year":"2004"},{"key":"10.1002\/14651858.CD008559.pub3-BIB0238|cit238","unstructured":"WHO 2016 International Classification of Diseases and Related Health Problems, 10th Revision apps.who.int\/classifications\/icd10\/browse\/2016\/en"},{"issue":"2","key":"10.1002\/14651858.CD008559.pub3-BIB0239|cit239","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1023\/A:1022673906401","article-title":"Obtaining systematic teacher reports of disruptive behavior disorders utilizing DSM-IV","volume":"26","author":"Wolraich","year":"1998","journal-title":"Journal of Abnormal Child Psychology"},{"issue":"8","key":"10.1002\/14651858.CD008559.pub3-BIB0240|cit240","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1093\/jpepsy\/jsg046","article-title":"Psychometric properties of the Vanderbilt ADHD diagnostic parent rating scale in a referred population","volume":"28","author":"Wolraich","year":"2003","journal-title":"Journal of Pediatric Psychology"},{"issue":"4","key":"10.1002\/14651858.CD008559.pub3-BIB0241|cit241","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1191\/1740774504cn032oa","article-title":"Are missing outcome data adequately handled? A review of published randomized controlled trials in major medical journals","volume":"1","author":"Wood","year":"2004","journal-title":"Clinical Trials"},{"issue":"2","key":"10.1002\/14651858.CD008559.pub3-BIB0242|cit242","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1037\/1040-3590.13.2.267","article-title":"Discriminative validity of parent report of hypomanic and depressive symptoms on the General Behavior Inventory","volume":"13","author":"Youngstrom","year":"2001","journal-title":"Psychological Assessment"},{"issue":"1","key":"10.1002\/14651858.CD008559.pub3-BIB0243|cit243","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1176\/ajp.143.1.35","article-title":"The overt aggression scale for the objective rating of verbal and physical aggression","volume":"143","author":"Yudofsky","year":"1986","journal-title":"American Journal of Psychiatry"},{"issue":"6 . Art. No.: C","key":"10.1002\/14651858.CD008559.pub3-BIB0244|cit244","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008559","article-title":"Atypical antipsychotics for disruptive behavioural disorders ininpatient or outpatient children and youths","author":"Loy","year":"2010","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD008559.pub3-BIB0245|cit245","first-page":"Art. No.: CD008","article-title":"Atypical antipsychotics for disruptive behaviour disorders in children and youths","volume":"9","author":"Loy","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD008559.pub3\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,13]],"date-time":"2021-07-13T08:41:38Z","timestamp":1626165698000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD008559.pub3"}},"subtitle":[],"editor":[{"name":"Cochrane Developmental, Psychosocial and Learning Problems Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2017,8,9]]},"references-count":245,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2017,8]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd008559.pub3","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,9]]}}}